The global cell culture media, sera and reagents market
is witnessing impressive growth due to the increase in demand for
biopharmaceutical products. Since its introduction as an integral part
of the life sciences industry, the cell culture market has witnessed
significant growth in terms of scope as well as adoption by the
end-users. The double-digit growth in the biotechnology and
biopharmaceutical industries is the major factor likely to boost the
growth of the cell culture media, sera and reagents market in the near
future.
The market has been extensively analyzed
on the basis of media, sera, reagents, and geography. Cell culture media
are further segmented into chemically defines media, classical media,
lysogeny broth, protein-free, serum-free and specialty media; segment
for cell culture sera is sub-segmented into fetal bovine serum, newborn
calf and adult bovine serum and others; and reagents segmented to
further divided into albumin, amino acids, attachment factors, growth
factors and cytokines, protease inhibitors, and others. Albumin market
is further studied for human serum albumin, bovine serum albumin, and
recombinant serum albumin. Growth factors and cytokines market is
studied for insulin-like growth factors, interleukins and interferons,
tumor necrosis factors and other growth factors and cytokines. The
others reagents segment is further divided in porcine trypsin,
recombinant trypsin, thrombin and miscellaneous reagents.
Each of the segments has been analyzed in
detail for market trends, recent developments, outlook, and
opportunities. The report provides current and future market size for
each segment and sub-segment for the period from 2013 to 2023, in terms
of revenue in USD million considering 2013 and 2014 as the base years.
The compound annual growth rate (% CAGR) for each market segment has
been provided for the forecast period from 2015 to 2023 along with the
estimations of market size.
Geographically, the global cell culture
media, sera and reagents market has been classified into five major
regions: North America (the U.S., Canada), Europe (Germany, the U.K.,
Rest of Europe), Asia Pacific (Japan, China, India, Korea, Rest of Asia
Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and
Rest of the World (RoW) (Israel and Russia). The regions have been
further segmented by media, sera and reagents. The current and future
market sizes in terms of revenue (USD million) of these regional markets
and their major countries have been provided in the report for the
period from 2013 to 2023, with their growth rate (%) for the period from
2015 to 2023. The study also offers a list of recommendations and
highlights of the market for new companies willing to enter the market
and for existing companies to increase market shares, which is likely to
help in the decision-making process.
The market overview section of the report
demonstrates the market dynamics and market trends such as drivers,
restraints, and opportunities that influence the current and future
status of the cell culture industry. The report also covers market
attractiveness analysis, Porter’s Five Forces Analysis and key market
share analysis in the market overview section, in order to give a
thorough analysis of the overall competitive scenario in the global cell
culture media, sera and reagents market.
The competitive landscape section of the
report includes the market share analysis of major players in the cell
culture media, sera and reagents market for the year 2013. The report
concludes with the company profiles section that includes key
information about the major players in the market. Key players profiled
in this report include BD Biosciences, Corning Incorporated, EMD
Millipore, GE Healthcare, Lonza Group, Sigma-Aldrich Corporation, Thermo
Fisher Scientific, Inc., VWR International, LLC, and PromoCell GmbH.
Each of these players is profiled in the report considering parameters
such as company overview, financial overview, business strategies,
product portfolio, and recent developments.
No comments:
Post a Comment